food and drug administration news

FDA Approves 1st New Schizophrenia Drug in Decades

FDA approves new type of schizophrenia drug

The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to schizophrenia treatment in decades,

The New York Times · 20h

F.D.A. Approves the First New Schizophrenia Drug in Decades

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Gizmodo · 3h

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. We may earn a commission when you buy through links on our sites.

Salmonella and Listeria Found in 2 Pet Food Brands

YAHOO!News · 23h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

CNET · 3h

Salmonella and Listeria Found in 2 Pet Food Brands: Everything to Know

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

NBC New York · 21h

FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk

Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the bacteria salmonella and listeria, which can cause illness in pets that can then infect their owners.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 20h

US FDA lifts clinical hold on Biomea's diabetes trials after safety review

The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday. The regulator had placed a hold on two trials of its lead drug,

Business Insider · 15h

Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up

Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing

MarketWatch · 1d

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

Sanofi blockbuster drug wins clearance in US for lung disease

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

Do not feed this to your pets: Dog, cat food recalled after illnesses

The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...

We need a Food and Drug Administration for AI

We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?

BioPharma Dive5h

FDA, after delay, clears Regeneron and Sanofi drug for COPD

Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.

McKnight's Long-Term Care News21h

Journalists question safety and effectiveness of new Alzheimer’s drug

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

13h

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

The overdose reversal drug Narcan is being distributed in old newspaper boxes

Naloxone, a nasal spray most commonly known as Narcan, is used as an emergency treatment to reverse drug overdoses.

Drug prices improved under Biden-Harris and Trump − but not for everyone, and not enough

Delving into the presidential candidates’ successes on a number of drug-pricing policies, you’ll see a continuation of progress across the administrations. Neither the Trump administration nor the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results